Fund Holdings — Paradigm Biocapital Advisors LP

Total Portfolio Value:
$2.34B
Total Bought:
$470.42M
Total Sold:
$296.89M
Net Transaction:
+$173.54M
Notable People:
Dr. Senai Nmn Asefaw
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Nuvalent Inc5,269,4335,269,4330$373.71M$402.06M17.17%+$28.35M
Arcellx Inc
COMMON STOCK
4,492,0324,649,016+156,984$294.68M$306.14M13.07%+$11.46M
Merus N V3,369,6994,281,954+912,255$141.83M$225.23M9.62%+$83.40M
Revolution Medicines, Inc.(RVMD)6,178,1116,093,291-84,820$218.46M$224.17M9.57%+$5.71M
Tarsus Pharmaceuticals, Inc.(TARS)2,610,1972,976,099+365,902$134.09M$120.56M5.15%-$13.52M
Vaxcyte, Inc.(PCVX)1,696,4813,372,837+1,676,356$64.06M$109.65M4.68%+$45.59M
BeOne Medicines AGADS(ONC)666,024347,787-318,237$181.27M$84.19M3.59%-$97.08M
Edgewise Therapeutics, Inc.(EWTX)4,394,5566,142,344+1,747,788$96.68M$80.53M3.44%-$16.15M
Cogent Biosciences, Inc.(COGT)8,963,65510,352,449+1,388,794$53.69M$74.33M3.17%+$20.64M
Janux Therapeutics, Inc.(JANX)3,329,9092,920,258-409,651$89.91M$67.46M2.88%-$22.45M
Crinetics Pharmaceuticals In1,946,1682,343,553+397,385$65.27M$67.40M2.88%+$2.13M
Disc Medicine, Inc.(IRON)1,210,9711,210,9710$60.11M$64.13M2.74%+$4.02M
Scholar Rock Holding Corporation(SRRK)01,600,554+1,600,554$0$56.69M2.42%+$56.69M
LENZ Therapeutics, Inc.(LENZ)1,511,9321,717,066+205,134$38.87M$50.33M2.15%+$11.46M
BridgeBio Pharma, Inc.(BBIO)0965,764+965,764$0$41.70M1.78%+$41.70M
Apogee Therapeutics Inc961,707958,630-3,077$35.93M$41.63M1.78%+$5.70M
MoonLake ImmunotherapeuticsCL A(MLTX)627,423878,323+250,900$24.51M$41.46M1.77%+$16.94M
Alkermes plcSHS(ALKS)01,375,569+1,375,569$0$39.36M1.68%+$39.36M
Viridian Therapeutics, Inc.(VRDN)2,095,0792,741,576+646,497$28.24M$38.33M1.64%+$10.09M
Agios Pharmaceuticals, Inc.(AGIO)01,142,511+1,142,511$0$38.00M1.62%+$38.00M
Ocular Therapeutix, Inc.(OCUL)1,314,0183,420,340+2,106,322$9.63M$31.74M1.36%+$22.11M
Olema Pharmaceuticals, Inc.(OLMA)6,741,1726,764,172+23,000$25.35M$28.82M1.23%+$3.47M
Spyre Therapeutics, Inc.(SYRE)2,127,2051,870,445-256,760$34.32M$28.00M1.20%-$6.32M
Y-Mabs Therapeutics Inc4,236,3464,236,3460$18.77M$19.11M0.82%+$338.9K
Pharvaris N V
COM
01,062,911+1,062,911$0$18.71M0.80%+$18.71M
Immatics N.V.SHS(IMTX)1,907,1083,144,157+1,237,049$8.60M$16.92M0.72%+$8.31M
Erasca, Inc.(ERAS)10,802,35411,907,182+1,104,828$14.80M$15.12M0.65%+$322.9K
Crescent Biopharma, Inc.(CBIO)0642,721+642,721$0$10.37M0.44%+$10.37M
Arcutis Biotherapeutics, Inc.(ARQT)1,465,3340-1,465,334$22.92M$0—-$22.92M
argenx SEADR(ARGX)59,6790-59,679$35.32M$0—-$35.32M
Cytokinetics, Incorporated(CYTK)858,6640-858,664$34.51M$0—-$34.51M
Insmed Incorporated(INSM)451,3590-451,359$34.43M$0—-$34.43M
Metsera Inc1,191,4620-1,191,462$32.43M$0—-$32.43M
Page 1 of 1
Paradigm Biocapital Advisors LP — 13F Holdings — Q2 2025 | TickerTrail